http://www.acc.org/Feed?clinicalTopicID=9d928ff7-0a69-4d5c-8ae4-9a5be446fc6b Clinical Topic Feed: Atrial Fibrillation/Supraventricular Arrhythmias en /Latest-in-Cardiology/Articles/2026/08/12/20/15/ai-enabled-clinician-13aug2026 In this episode, Drs. Ami Bhatt, Rupal O’Quinn, and Leon Ptaszek delve into the role of consumer wearables in cardiovascular care. 1786636800000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/COMBINE-AF Clinically relevant extracranial bleeding affected approximately one in four patients receiving oral anticoagulation (OAC) for atrial fibrillation (AFib) over two years, potentially providing a more comprehensive measure of bleeding burden than major bleeding alone, according to a recent COMBINE-AF analysis published in Circulation. 1786546740000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/08/10/15/19/MERCURI-2 Starting dapagliflozin one day before elective cardiac surgery reduced the incidence of postoperative acute kidney injury (AKI) during the first seven days after surgery, according to results from the double-blind, placebo-controlled MERCURI-2 trial published July 30 in JAMA. 1786471800000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/29/13/18/eagles-eye-view-29jul2026 In this week’s View, Dr. Eagle looks at a post-hoc analysis of the API-CAT trial that showed recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival of patients with cancer-associated thrombosis. 1785331140000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/28/17/19/OPTIMA-AF Only one month of dual antithrombotic therapy followed by direct oral anticoagulant (DOAC) monotherapy proved to be noninferior in terms of efficacy and superior in terms of bleeding outcomes to the standard 12-month dual antithrombotic therapy post PCI among patients with atrial fibrillation (AFib), according to results of the OPTIMA-AF trial published July 15 in The Lancet. 1785260580000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/27/15/29/If-You-Build-It-Will-They-Come Atrial fibrillation (AF) is the most common sustained arrhythmia in the United States, with a nation-wide prevalence projected to reach 12.1 million by 2030.1 AF is a major driver of adverse clinical outcomes, including stroke, dementia, myocardial infarction, sudden cardiac death, heart failure, chronic kidney disease, and all-cause death. 1785173940000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/22/17/25/Updated-ACC-ECDP-Addresses-Management-of-HFpEF The updated 2026 ACC Expert Consensus Decision Pathway (ECDP) for the Management of Heart Failure With Preserved Ejection Fraction (HFpEF) reflects a significant evolution in how HFpEF is understood and treated. 1784820720000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/22/17/25/Influenza-Vaccination Influenza vaccination was associated with lower risks of incident atrial fibrillation (AFib) and multiple cardiovascular outcomes, according to an observational cohort study published July 11 in EHJ. The findings support vaccination as a potential AFib prevention strategy and underscore the need for randomized trials focused on AFib-related outcomes. 1784742720000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/22/13/15/eagles-eye-view-22jul2026 In this week’s View, Dr. Eagle looks at age, body mass index (BMI), and cardiovascular outcomes after transcatheter aortic valve replacement (TAVR). 1784726220000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/15/17/28/Multisociety-Statement A new expert consensus statement calls for the immediate adoption of safer technologies that are now available to protect health care professionals performing minimally invasive procedures in cath labs from the well-known and preventable hazards of radiation exposure and orthopedic injuries. 1784137320000 Articles and Stories